Literature DB >> 18667425

Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.

Emmanuel Fenouillet1, Dimitri Lavillette, Silvia Loureiro, George Krashias, Guillemette Maurin, François-Loïc Cosset, Ian M Jones, Rym Barbouche.   

Abstract

Disulfide bonding contributes to the function and antigenicity of many viral envelope glycoproteins. We assessed here its significance for the hepatitis C virus E2 envelope protein and a counterpart deleted for hypervariable region-1 (HVR1). All 18 cysteine residues of the antigens were involved in disulfides. Chemical reduction of up to half of these disulfides was compatible with anti-E2 monoclonal antibody reaction, CD81 receptor binding, and viral entry, whereas complete reduction abrogated these properties. The addition of 5,5'-dithiobis-2-nitrobenzoic acid had no effect on viral entry. Thus, E2 function is only weakly dependent on its redox status, and cell entry does not require redox catalysts, in contrast to a number of enveloped viruses. Because E2 is a major neutralizing antibody target, we examined the effect of disulfide bonding on E2 antigenicity. We show that reduction of three disulfides, as well as deletion of HVR1, improved antibody binding for half of the patient sera tested, whereas it had no effect on the remainder. Small scale immunization of mice with reduced E2 antigens greatly improved serum reactivity with reduced forms of E2 when compared with immunization using native E2, whereas deletion of HVR1 only marginally affected the ability of the serum to bind the redox intermediates. Immunization with reduced E2 also showed an improved neutralizing antibody response, suggesting that potential epitopes are masked on the disulfide-bonded antigen and that mild reduction may increase the breadth of the antibody response. Although E2 function is surprisingly independent of its redox status, its disulfide bonds mask antigenic domains. E2 redox manipulation may contribute to improved vaccine design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667425      PMCID: PMC3258924          DOI: 10.1074/jbc.M805221200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Oxidative protein folding: an update.

Authors:  Adam M Benham
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

2.  An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.

Authors:  Birke Bartosch; Géraldine Verney; Marlène Dreux; Peggy Donot; Yoann Morice; François Penin; Jean-Michel Pawlotsky; Dimitri Lavillette; Francois-Loïc Cosset
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.

Authors:  Dimitri Lavillette; Alexander W Tarr; Cécile Voisset; Peggy Donot; Birke Bartosch; Christine Bain; Arvind H Patel; Jean Dubuisson; Jonathan K Ball; François-Loïc Cosset
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

4.  Acid-resistant bovine pestivirus requires activation for pH-triggered fusion during entry.

Authors:  Thomas Krey; Heinz-Jürgen Thiel; Till Rümenapf
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 5.  The protein disulphide-isomerase family: unravelling a string of folds.

Authors:  D M Ferrari; H D Söling
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

6.  Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.

Authors:  S Navas; J Martín; J A Quiroga; I Castillo; V Carreño
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.

Authors:  Jin-Won Youn; Su-Hyung Park; Dimitri Lavillette; Francois-Loic Cosset; Se-Hwan Yang; Chang Geun Lee; Hyun-Tak Jin; Chang-Min Kim; Mohamed Tarek M Shata; Dong-Hun Lee; Wolfram Pfahler; Alfred M Prince; Young Chul Sung
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

Review 8.  Oxidative protein folding in the mammalian endoplasmic reticulum.

Authors:  C E Jessop; S Chakravarthi; R H Watkins; N J Bulleid
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

Review 9.  Disulfide bonds and the stability of globular proteins.

Authors:  S F Betz
Journal:  Protein Sci       Date:  1993-10       Impact factor: 6.725

10.  Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env.

Authors:  Rym Barbouche; Hugues Lortat-Jacob; Ian M Jones; Emmanuel Fenouillet
Journal:  Mol Pharmacol       Date:  2005-01-11       Impact factor: 4.436

View more
  7 in total

1.  An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus.

Authors:  Ruikun Du; Manli Wang; Zhihong Hu; Hualin Wang; Fei Deng
Journal:  Virol Sin       Date:  2015-09-30       Impact factor: 4.327

2.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

3.  The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule.

Authors:  Thomas Krey; Jacques d'Alayer; Carlos M Kikuti; Aure Saulnier; Laurence Damier-Piolle; Isabelle Petitpas; Daniel X Johansson; Rajiv G Tawar; Bruno Baron; Bruno Robert; Patrick England; Mats A A Persson; Annette Martin; Félix A Rey
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

4.  Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain.

Authors:  Jillian Whidby; Guaniri Mateu; Hannah Scarborough; Borries Demeler; Arash Grakoui; Joseph Marcotrigiano
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

5.  Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.

Authors:  Johanna Fraser; Irene Boo; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

Review 6.  Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.

Authors:  Yimin Tong; Dimitri Lavillette; Qingchao Li; Jin Zhong
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

7.  Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen.

Authors:  Andrey M Grishin; Nataliya V Dolgova; Shelby Landreth; Olivier Fisette; Ingrid J Pickering; Graham N George; Darryl Falzarano; Miroslaw Cygler
Journal:  J Mol Biol       Date:  2021-11-12       Impact factor: 6.151

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.